| Primary information |
|---|
| sequence ID | Seq_7182 |
| Peptide sequence | SHALQLNNRQI |
| CancerPDF_ID | CancerPDF_ID883, CancerPDF_ID12190, |
| PMID | 19795908,26992070 |
| Protein Name | Complement C4-B,Complement C4-B |
| UniprotKB Entry Name | CO4B_HUMAN,CO4B_HUMAN |
| Fluid | Plasma,Serum |
| M/Z | 647.35,1292.6949 |
| Charge | 2,NA |
| Mass (in Da) | NA,1293.704637 |
| fdr | NA,NA |
| Profiling Technique | LC-MS,LC-MS |
| Peptide Identification technique | MALDI-TOF/TOF,LC-MS/MS |
| Quantification Technique | LC-MRM (multiple reaction monitoring),NA |
| Labelled/Label Free | Labelled,Label Free |
| FDR | less than 7%,FDR 1 % |
| CancerPDF_ID | CancerPDF_ID883, CancerPDF_ID12190, |
| p-Value | NA,NA |
| Software | FlexAnalysis 3.0 and Biotools 3.0 software,SEQUEST and Maxquant |
| Length | 11,11 |
| Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Melanoma |
| Database | NCBI refseq Protein Database,SwissProt Database |
| Modification | NA,NA |
| Number of Patients | "42 normal, 28 patients",8 cancer samples and 4 healthy samples |
| Regulation | NA,"Present in 3 cancer samples out of 8 cancer samples. ,Present in 0 healthy samples out of 4 healthy samples." |
| Validation | NA,na |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | NA |
| IEDB | |